Tag Archives: fungal meningitis outbreak

Featured Stories
FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Image Source: saidaonline.com

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Louisiana Whistleblower Lawsuit Revived

Louisiana Whistleblower Lawsuit Revived

A state appeals court in Louisiana has ruled that a former employee of Rapides Parish Coliseum can proceed with a whistleblower lawsuit against the Coliseum Authority.

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

FDA lacked jurisdiction to enforce violations at NECC in the past, was slow to release inspection results

As the Food and Drug Administration aims to assert more authority in regulating drug compounding pharmacies like the one responsible for the deadly nationwide outbreak of fungal meningitis, details have emerged that the agency has previously tried to flex regulatory … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals | Tagged , , , |

Senators promise action to prevent the next fungal meningitis outbreak

Lawmakers on Capitol Hill have promised to update federal regulations, namely with the Food and Drug Administration, that would bring pharmaceutical drug compounding labs under the agency’s eye in the future in hopes of avoiding situations like the current deadly … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Product Recalls | Tagged , , |

Ameridose shares more than owners with embattled compounding center

Conditions at Ameridose, a Massachusetts-based pharmaceutical drug supplier that shares some of the same owners as the company tied to the deadly nationwide outbreak of fungal meningitis, are such that it can not guarantee the safety of any of the … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged , |

Main threat of fungal meningitis passes, health officials warn victims not yet in the clear

The primary threat posed by contaminated epidural steroid injection that’s been linked to a nationwide outbreak of fungal meningitis has passed but those who received the drugs are not in the clear just yet. According to an ABC News report, … Continue reading

Posted in Pharmaceuticals | Tagged |

Stress, worry plague those injected with contaminated steroid drug

For the thousands who received a contaminated epidural steroid injection in the last few months, the next few days and weeks will be filled with worry and stress as they wonder if they’ll be the next victims in the deadly … Continue reading

Posted in Pharmaceuticals | Tagged |

Variety of lawsuits filed in response to fungal meningitis outbreak

The victims of the deadly fungal meningitis outbreak have already begun to seek justice for their injuries or if they’ve lost a loved one who received a contaminated epidural steroid injection. According to a Reuters report, victims have two choices … Continue reading

Posted in Defective Products, Legal News, Malpractice, Pharmaceuticals | Tagged |

Conditions inside New England Compounding Center conducive to contamination

The drug compounding lab likely responsible for the deadly nationwide outbreak of fungal meningitis ignored many safety protocols designed to ensure sterility of its products. According to a New York Times report this week, health officials in Massachusetts released a … Continue reading

Posted in Pharmaceuticals | Tagged |

Skepticism of company at center of fungal meningitis outbreak continues to grow

The company at the center of the deadly fungal meningitis outbreak has been under increased oversight since a 2006 inspection of its pharmacy labs discovered widespread deficiencies in protocols for manufacturing drugs. According to an AP report, New England Compounding … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , |

Questions, concerns mount against New England Compounding Center as fungal meningitis outbreak widens

Health officials across the country fear that many of the other compounded or mixed drugs leaving the pharmacies at New England Compounding Center may be just as contaminated as the epidural steroid drug that has caused a deadly nationwide outbreak … Continue reading

Posted in Pharmaceuticals | Tagged |

More Floridians affected by fungal meningitis outbreak, third death in state reported

Health officials in Florida have confirmed a third death in the state linked to the nationwide outbreak of fungal meningitis. According to a WESH-TV report in Orlando, Fla., Florida’s Dept. of Health said Wednesday that a third person who received … Continue reading

Posted in Pharmaceuticals | Tagged |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.